◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
KAKEN PHARMACEUTICAL CO.,LTD. — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemQ4 2025Nov 13, 2025Q4 2024Nov 13, 2024Q1 2024Mar 31, 2024Q1 2023Mar 31, 2023Q1 2022Mar 31, 2022Q1 2021Mar 31, 2021
+Operating Income 19.6B 5.5B -- -- -- --
Operating Margin % 98.8% 96.3% -- -- -- --
+Ordinary Income 19.8B 5.7B -- -- -- --
Revenue Growth % 246.4% -- -- -- -- --
Line ItemQ4 2025Nov 13, 2025Q4 2024Nov 13, 2024Q1 2024Mar 31, 2024Q1 2023Mar 31, 2023Q1 2022Mar 31, 2022Q1 2021Mar 31, 2021
Current Assets 111.4B 107.0B -- -- -- --
Total Assets 190.4B 171.6B 171.7B 165.1B 163.3B 160.6B
Current Liabilities 30.4B 19.0B -- -- -- --
Total Liabilities 37.8B 27.9B 30.9B 27.2B 27.6B 28.6B
Total Equity 152.6B 143.8B 140.7B 137.9B 135.7B 132.0B
Equity Ratio -- -- 0.82 0.83 0.83 0.82
No data available for this statement.
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...